CDC warns of disruptions to ADHD meds after $100M fraud arrest

The CDC has issued a warning about potential disruptions in access to ADHD medications following the arrest of two executives involved in a $100 million fraud scheme. The CEO and clinical president of a California-based digital health company were arrested for allegedly attempting to illegally distribute Adderall over the internet, submitting false healthcare claims, and obstructing justice. This situation could affect patients who rely on stimulant medications for ADHD, especially those using telehealth services. The disruption comes amid an ongoing prescription drug shortage that includes ADHD medications. The DOJ stated that the executives exploited the COVID-19 pandemic to defraud taxpayers and provide easy access to controlled substances without legitimate medical purposes. The CDC advises obtaining medication only from licensed clinicians and pharmacies due to the ongoing threats of drug overdose deaths and the illegal drug market.

Source: Rochester First